TMPRSS2:ERG gene fusion predicts subsequent detection of prostate cancer in patients with high-grade prostatic intraepithelial neoplasia.
about
Molecular pathways and targets in prostate cancerDe novo large cell neuroendocrine carcinoma of the prostate, case report and literature reviewThe biology of castration-resistant prostate cancerThe transcription factor ERG increases expression of neurotransmitter receptors on prostate cancer cells.YB-1 and MTA1 protein levels and not DNA or mRNA alterations predict for prostate cancer recurrenceThe TMPRSS2-ERG Gene Fusion Blocks XRCC4-Mediated Nonhomologous End-Joining Repair and Radiosensitizes Prostate Cancer Cells to PARP InhibitionRNA biomarkers to facilitate the identification of aggressive prostate cancerMolecular evidence that invasive adenocarcinoma can mimic prostatic intraepithelial neoplasia (PIN) and intraductal carcinoma through retrograde glandular colonization.The role of biomarkers in the assessment of prostate cancer risk prior to prostate biopsy: which markers matter and how should they be used?Prognostic histopathological and molecular markers on prostate cancer needle-biopsies: a reviewCompeting endogenous RNA interplay in cancer: mechanism, methodology, and perspectives.DESNT: A Poor Prognosis Category of Human Prostate Cancer.ERG expression in prostate cancer: biological relevance and clinical implication.Somatic Mutation Analyses in Studies of the Clonal Evolution and Diagnostic Targets of Prostate Cancer.Prostate cancer in Jordanian-Arab population: ERG status and relationship with clinicopathologic characteristics.Molecular subtyping of prostate cancer.TMPRSS2:ERG fusion gene occurs less frequently in Chinese patients with prostate cancer.Clinical variability and molecular heterogeneity in prostate cancer.NKX3.1 Suppresses TMPRSS2-ERG Gene Rearrangement and Mediates Repair of Androgen Receptor-Induced DNA DamagemiRNAs as drivers of TMPRSS2-ERG negative prostate tumors in African American men.Androgen Signaling in Prostate Cancer.TMPRSS2-ERG Gene Fusions in Prostate Cancer of West African Men and a Meta-analysis of Racial Differences.Deletion of Interstitial Genes between TMPRSS2 and ERG Promotes Prostate Cancer Progression.GILT--A randomised phase III study of oral vinorelbine and cisplatin with concomitant radiotherapy followed by either consolidation therapy with oral vinorelbine and cisplatin or best supportive care alone in stage III non-small cell lung cancer.Mutation Profiling Indicates High Grade Prostatic Intraepithelial Neoplasia as Distant Precursors of Adjacent Invasive Prostatic Adenocarcinoma.Considering race and the potential for ERG expression as a biomarker for prostate cancer.ERG and PTEN status of isolated high-grade PIN occurring in cystoprostatectomy specimens without invasive prostatic adenocarcinoma.Utility of PTEN and ERG immunostaining for distinguishing high-grade PIN from intraductal carcinoma of the prostate on needle biopsy.ERG overexpression plus SLC45A3 (prostein) and PTEN expression loss: Strong association of the triple hit phenotype with an aggressive pathway of prostate cancer progression.Domain retention in transcription factor fusion genes and its biological and clinical implications: a pan-cancer study.Association of ERG and TMPRSS2-ERG with grade, stage, and prognosis of prostate cancer is dependent on their expression levels.A mini-review of quality of life as an outcome in prostate cancer trials: patient-centered approaches are needed to propose appropriate treatments on behalf of patients.
P2860
Q34365632-9C4746A8-757E-4840-84BF-C76DB19922D0Q34978736-579D14B5-E9AE-45EA-B3D7-00DC5999CE87Q35039889-D65D3A28-3C40-4732-B9D5-25105140A0B6Q35756563-C1234831-437C-4CC9-8223-F6D4B9BAB171Q35781327-85910080-7D59-4E0E-B680-C84C39FB7E13Q35930506-E7F7C55F-F84F-4814-8AA9-CA8D1913E5D4Q36260364-F3579FD3-8F08-4FE5-AC2B-EA3282C3E75FQ36469889-3AD2B0F1-52E3-400F-B31F-8DDEF2775D1DQ38211603-6E253338-40B3-45A5-9FB4-0AAB4B66CAD8Q38253055-9F4876F0-BB3A-4BE7-8B39-28C9F403863EQ38325485-4CE86EE1-CB71-41FE-ACC8-6E077776D4DBQ38655020-AA3C64C6-8022-4A7F-B053-6070FDF64AD0Q38681610-8336AC63-6A0F-41D6-A647-6685902BA5EDQ38703676-95D29300-C97A-4E0F-994F-842758926EAFQ38760532-3531E6DE-0D76-4E7D-853F-E67BF7C79BA5Q38778266-10ABA194-377C-4DEC-A2F5-08A99FAB5E55Q38805821-5331B0EF-C207-4088-9D3F-A9B5EE09EDCFQ38808811-51CAA99B-49CE-4B74-AD76-3F3BF3EACE75Q38874548-8A323FF1-2426-4AB1-B1E7-AA3C0B22FEE4Q39214638-035C0EE8-4BA7-4EB3-B17D-2AB4BC01C5B5Q39227656-A43318D5-633A-4435-A3CD-467A297798CBQ39386421-102888D5-873B-4AE2-B41A-21AA5D02D03EQ40908009-B976D8BB-26FC-4B58-9C43-53C489FAFE2BQ40951849-6910798B-EDA5-49BF-9C32-4A7611763646Q40996353-B75CB154-751D-435E-BCF6-0D1D7C96D150Q42176098-E6418A2D-9C24-4AC5-B0FA-E9D9A4B9B1A1Q42363171-5246E9DC-EB73-4EA2-A9A1-5E2A52E7E390Q43104641-1161D7FB-4533-4D1E-ADC6-5C0C8E7D2306Q43269413-8D7E9D2C-9E0F-4287-AAFF-CA7425DF9ABDQ47164118-63FD2D3D-E134-4008-8902-80C01F8C6DE0Q53519887-5510D0C3-F50D-4F0A-AC65-81FBF6AEF41DQ55252859-6E0CB696-38DC-4DA3-B63C-839CDE733A01
P2860
TMPRSS2:ERG gene fusion predicts subsequent detection of prostate cancer in patients with high-grade prostatic intraepithelial neoplasia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
TMPRSS2:ERG gene fusion predic ...... tic intraepithelial neoplasia.
@en
TMPRSS2:ERG gene fusion predic ...... tic intraepithelial neoplasia.
@nl
type
label
TMPRSS2:ERG gene fusion predic ...... tic intraepithelial neoplasia.
@en
TMPRSS2:ERG gene fusion predic ...... tic intraepithelial neoplasia.
@nl
prefLabel
TMPRSS2:ERG gene fusion predic ...... tic intraepithelial neoplasia.
@en
TMPRSS2:ERG gene fusion predic ...... tic intraepithelial neoplasia.
@nl
P2093
P2860
P50
P356
P1476
TMPRSS2:ERG gene fusion predic ...... tic intraepithelial neoplasia.
@en
P2093
David G Bostwick
Kyung Park
Michael L Hancock
Mitchell S Steiner
Ramesh Narayanan
P2860
P304
P356
10.1200/JCO.2013.49.8386
P407
P577
2013-12-02T00:00:00Z